IL7 and head and neck squamous cell carcinoma: Other developments include the description of MUC1-CAR T cells with IL-22 secretion in head and neck squamous cell carcinoma (HNSCC)24 or an inverted cytokine receptor (IL-4/IL-7) in breast cancer model12.